Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging: The role of delayed imaging

Clinical Nuclear Medicine

Volumn 24, Issue 8, 1999, Pages 590-593

  Derebek, Erkan ^a   Balci, Pinar ^a   Alanyali, Hilmi ^a   Kocdor, Mehmet Ali ^a   Capa, Gamze ^a   Gorken, Ilknur Bilkay ^a   Degirmenci, Berna ^a   Alakavuklar, Mehmet ^a   Canda, Tulay ^a   Durak, Hatice ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Chemotherapy; Radiotherapy; Tc 99m sestamibi

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GADOLINIUM PENTETATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; BILATERAL CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTIMAMMOGRAPHY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0032783191     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199908000-00009     Document Type: Article

References (18)

1. Donovan AJ: Bilateral breast cancer. Surg Clin North Am 5:1141, 1990.
2. Fechner RE: Infiltrating lobular carcinoma without lobular carcinoma in situ. Cancer 29:1539, 1972.
3. Lesser M, Rosen PP, Kinne D: Multicentricity and bilaterality in invasive lobular carcinoma. Cancer 31:110, 1973.
4. Horn PL, Thomson WD: Risk of contralateral breast cancer: Association with histologic, clinical and therapeutic factors. Cancer 62:412, 1988.
5. Silverstein MJ, Lewinsky B, Waisman J, et al: Infiltrating lobular carcinoma: Is it different from infiltrating duct carcinoma? Cancer 73:1673, 1994.
6. Sastre-Garau X, Jouve M, Asselain B, et al: Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy. Cancer 77:113, 1996.
7. Waxman AD: The role of Tc-99m methoxyisobutylisonitrile in imaging breast cancer. Sem Nucl Med 1:40, 1997.
8. Ohta H, Komibuchi T, Nishio T, et al: Three patients with bilateral breast tumors examined by technetium-99m-sestamibi scintimammography. Ann Nucl Med 11:259, 1997.
9. Howell A, Harris M: Infiltrating lobular carcinoma of the breast. BMJ 291:1371, 1985.
10. Krecke KN, Gisvold JJ: Invasive lobular carcinoma of the breast: Invasive lobular carcinoma and extend of disease at diagnosis in 184 patients. AJR 161:957, 1993.
11. Hilleron DJ, Anderson IT, Lindholm K, Linnell F: Invasive lobular carcinoma: Mammographic findings in a 10-year experience. Radiology 178:149, 1991.
12. Cody HS: Routine contralateral breast biopsy: Helpful or irrelevant? Experience in 871 patients, 1977-1993. Ann Surg 4:370, 1997.
13. Heywang SA, Wolf A, Pruss E, et al: MR imaging of the breast with Gd-DTPA: Use and limitations. Radiology 171: 95, 1989.
14. Orel SG, Schnall MD, Livolsi VA, Troupin RH: Suspicious breast lesions: MR imaging with radiologie-pathologie correlation. Radiology 190:485, 1994.
15. Burak Z, Argon M, Memis A, et al: Evaluation of palpable breast masses with Tc-99m MIBI: A comparative study with mammography and ultrasonography. Nucl Med Commun 15: 604, 1994.
16. Khalkhali I, Mena I, Diggless L: Review of imaging techniques for the diagnosis of breast cancer: A new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 21:357, 1994.
17. Taillefer R, Robidoux A, Lambert R, et al: Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36:1758, 1995.
18. Moretti JL, Azaloux H, Boisseron D, et al: Primary breast cancer with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 23:980, 1994.